The announcement of a class action lawsuit against Humacyte, Inc. is likely to negatively impact its stock price in the short term as investors may react to the potential legal and financial consequences. Legal issues can lead to uncertainty and potential financial liabilities, which often result in a decrease in investor confidence and stock price.